<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this retrospective study was to assess the contribution of <z:chebi fb="0" ids="37804">thallium-201</z:chebi> single-<z:chebi fb="23" ids="30212">photon</z:chebi> emission tomography (SPET) in the detection and differential diagnosis of <z:e sem="disease" ids="C0006118" disease_type="Neoplastic Process" abbrv="">brain tumours</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In 90 patients <z:chebi fb="0" ids="37804">201Tl</z:chebi> SPET was performed because of clinical or radiological suspicion of tumoral invasion, completed by <z:chebi fb="1" ids="33353">technetium</z:chebi>-99m hexamethylpropylene <z:chebi fb="39" ids="32952">amine</z:chebi> <z:chebi fb="0" ids="25750">oxime</z:chebi> and 99mTc-sestamibi SPET in some patients </plain></SENT>
<SENT sid="2" pm="."><plain>For <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, diagnosis was based on biopsy or autopsy </plain></SENT>
<SENT sid="3" pm="."><plain>Other diagnoses were made only after clinical and radiological follow-up for at least 6 months </plain></SENT>
<SENT sid="4" pm="."><plain>Histologically <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> consisted of <z:hpo ids='HP_0009592'>astrocytoma</z:hpo> stage I or II (number of patients, n = 6), <z:hpo ids='HP_0009592'>astrocytoma</z:hpo> stage III (n = 8), <z:hpo ids='HP_0100843'>glioblastoma</z:hpo> multiforme (n = 14) and <z:mpath ids='MPATH_252'>oligodendroglioma</z:mpath> (n = 3), <z:e sem="disease" ids="C0220650" disease_type="Neoplastic Process" abbrv="">brain metastasis</z:e> (n = 14), <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 3), <z:hpo ids='HP_0002858'>meningioma</z:hpo> (n = 3), <z:hpo ids='HP_0002893'>pituitary adenoma</z:hpo> (n = 2), <z:e sem="disease" ids="C0031941" disease_type="Neoplastic Process" abbrv="">pineal tumour</z:e> (n = 1), colloid <z:mpath ids='MPATH_62'>cyst</z:mpath> (n = 1) and <z:mpath ids='MPATH_257'>craniopharyngioma</z:mpath> (n = 1) </plain></SENT>
<SENT sid="5" pm="."><plain>False-negative studies included <z:e sem="disease" ids="C0031941" disease_type="Neoplastic Process" abbrv="">pineal tumour</z:e> (n = 1), colloid <z:mpath ids='MPATH_62'>cyst</z:mpath> (n = 1), <z:mpath ids='MPATH_257'>craniopharyngioma</z:mpath> (n = 1), <z:hpo ids='HP_0009592'>astrocytomas</z:hpo> stage I or II (n = 6) and stage III (n = 3), <z:mpath ids='MPATH_252'>oligodendroglioma</z:mpath> (n = 2) and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in the brain stem (n = 1) </plain></SENT>
<SENT sid="6" pm="."><plain>Additional <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> approximately &lt; 1.5 cm were not detected in two patients and <z:chebi fb="0" ids="37804">201Tl</z:chebi> SPET underestimated tumoral extent in one patient suffering from <z:hpo ids='HP_0100843'>glioblastoma</z:hpo> multiforme (n = 1) </plain></SENT>
<SENT sid="7" pm="."><plain>A false-positive study was obtained in a patient with skull <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (n = 1) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 15 patients who were finally shown to suffer from ischaemic infarction had a <z:mpath ids='MPATH_458'>normal</z:mpath> SPET study 9-28 days after the <z:hpo ids='HP_0003674'>onset</z:hpo> of symptomatology </plain></SENT>
<SENT sid="9" pm="."><plain>Of five patients with haemorrhagic infarction, studied within 2 weeks, four were false-positive </plain></SENT>
<SENT sid="10" pm="."><plain>Of six patients with intracranial haemorrhage, studied 9-39 days later, one showed focal <z:chebi fb="0" ids="37804">201Tl</z:chebi> accumulation </plain></SENT>
<SENT sid="11" pm="."><plain>Two further false-positive studies consisted of <z:mp ids='MP_0002947'>angioma</z:mp> and <z:hpo ids='HP_0100310'>epidural haematoma</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Finally, SPET studies were <z:mpath ids='MPATH_458'>normal</z:mpath> in six patients with definite diagnosis of (reactive) <z:hpo ids='HP_0002171'>gliosis</z:hpo> (n = 3), <z:e sem="disease" ids="C0270786" disease_type="Disease or Syndrome" abbrv="">Binswanger</z:e>'s <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> (n = 1), postinfectious <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> (n = 1) and multiple <z:mp ids='MP_0000612'>sclerosis</z:mp> (n = 1) </plain></SENT>
<SENT sid="13" pm="."><plain>In the patient population presented, sensitivity of <z:chebi fb="0" ids="37804">201Tl</z:chebi> SPET for supratentorial <z:e sem="disease" ids="C0006118" disease_type="Neoplastic Process" abbrv="">brain tumours</z:e> was 71.7% and specificity was 80.9% </plain></SENT>
<SENT sid="14" pm="."><plain>Clinical information and control SPET studies in combination with early, 30-min and 3- to 4-h delayed imaging may be expected to improve on these figures </plain></SENT>
<SENT sid="15" pm="."><plain>On the other hand it seems that, in addition to tumoral histology, the presence of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> in the fossa posterior and small volumes contribute to the occurrence of false-negative <z:chebi fb="0" ids="37804">201Tl</z:chebi> SPET studies </plain></SENT>
</text></document>